Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
Alavian
Seyed-Moayed
SM
Tabatabaei
Seyed-Vahid
SV
D000755:Anemia, Sickle Cell / Q000150:complications; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*; D016896:Treatment Outcome; D017086:beta-Thalassemia / Q000150:complications
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons